‍ ‍

Cocoa Flavanols: Research

Overview

‍ ‍

This page provides a curated overview of selected peer-reviewed scientific studies examining cocoa flavanols, polyphenolic compounds derived from cacao beans (Theobroma cacao). The goal of this page is to provide transparent access to commonly cited research in the scientific literature. The summaries below describe findings reported in published studies. They are presented for educational purposes as part of a clinician-led review of the scientific literature.

Important Context for Readers

Scientific studies examine outcomes in defined populations under specific research conditions. Results reported in individual studies may not apply to all individuals, and findings should not be interpreted as guaranteed outcomes. This page summarizes selected research examining vascular and endothelial function, blood pressure, cognitive function, metabolic biomarkers, and exercise-related physiology studied in relation to cocoa flavanols. It is not intended to provide medical advice, diagnosis, or treatment recommendations. This page is provided for educational purposes and does not include product recommendations or affiliate links.

‍Summary of Evidence

‍Across human clinical studies and meta-analyses, cocoa flavanol supplementation has been studied for its potential associations with endothelial function, vascular responsiveness, blood pressure, cognitive performance, and selected metabolic biomarkers.

While results vary across study populations and trial designs, the most consistent evidence relates to endothelial function and vascular physiology. Blood pressure effects appear modest. Evidence for cognitive function, metabolic biomarkers, and exercise performance remains more heterogeneous. Many studies involve short intervention periods, surrogate physiological outcomes, proprietary standardized extracts, and specific populations, which may limit generalizability.

‍Key Areas of Research

Vascular and Endothelial Support

Evidence strength: Moderate to Strong.

Randomized trials and meta-analyses have consistently evaluated cocoa flavanols for endothelial function, often using flow-mediated dilation as a marker of vascular responsiveness.

1) Hooper L, Kay C, Abdelhamid A, et al. Effects of chocolate, cocoa, and flavan-3-ols on cardiovascular health: a systematic review and meta-analysis of randomized trials. Am J Clin Nutr. 2012.

PMID: 22301923

DOI: https://doi.org/10.3945/ajcn.111.023457

Population: Adults across randomized controlled trials evaluating cocoa, chocolate, or flavan-3-ol interventions.

Design: Systematic review and meta-analysis of randomized controlled trials.

Key findings:
• Flow-mediated dilation improved in both acute and chronic intervention studies
• Insulin resistance markers improved in pooled analyses
• Blood pressure effects were modest and varied across studies
• Authors noted heterogeneity and the need for larger, longer-duration trials

2) Heiss C, Kleinbongard P, Dejam A, et al. Acute consumption of flavanol-rich cocoa and the reversal of endothelial dysfunction in smokers. J Am Coll Cardiol. 2005.

PMID: 16198842

DOI: https://doi.org/10.1016/j.jacc.2005.06.055

Population: Adult smokers with impaired endothelial function.

Design: Randomized, controlled, crossover clinical study evaluating acute flavanol-rich cocoa intake.

Key findings:
• Flavanol-rich cocoa improved endothelial function under study conditions
• Effects were associated with nitric oxide–related vascular physiology
• Findings helped establish cocoa flavanols as a clinically relevant area of endothelial-function research

3) Faridi Z, Njike VY, Dutta S, et al. Acute dark chocolate and cocoa ingestion and endothelial function: a randomized controlled crossover trial. Am J Clin Nutr. 2008.

PMID: 18614724

DOI: https://doi.org/10.1093/ajcn/88.1.58

Population: Adults evaluated for acute endothelial-function responses.

Design: Randomized, controlled, crossover trial evaluating dark chocolate and cocoa ingestion.

Key findings:
• Acute cocoa or dark chocolate intake improved endothelial function measures under study conditions
• Findings support short-term vascular responsiveness following flavanol-containing cocoa intake
• Results should be interpreted in the context of acute surrogate outcomes rather than long-term clinical events

Blood Pressure Support       

Evidence strength: Moderate.

Multiple randomized trials and meta-analyses suggest cocoa flavanols may modestly support healthy blood pressure regulation, particularly in individuals with higher baseline blood pressure.

4) Ried K, Fakler P, Stocks NP. Effect of cocoa on blood pressure. Cochrane Database Syst Rev. 2017.

PMID: 28439881

DOI: https://doi.org/10.1002/14651858.CD008893.pub3

Population: Adults across randomized controlled trials evaluating cocoa products and blood pressure outcomes.

Design: Cochrane systematic review and meta-analysis.

Key findings:
• Cocoa products were associated with modest blood pressure reductions in pooled analyses
• Effects varied by baseline blood pressure, dose, and study duration
• The authors emphasized that most trials were short-term and heterogeneous

5) Taubert D, Roesen R, Lehmann C, et al. Effects of low habitual cocoa intake on blood pressure and bioactive nitric oxide: a randomized controlled trial. JAMA. 2007.

PMID: 17609490

DOI: https://doi.org/10.1001/jama.298.1.49

Population: Adults with untreated upper-range blood pressure or stage 1 hypertension.

Design: Randomized controlled trial evaluating low-dose dark chocolate intake compared with white chocolate.

Key findings:
• Modest reductions in blood pressure were reported in the dark chocolate group
• Findings were associated with changes in nitric oxide bioavailability
• The study supports cocoa-related vascular physiology, though food-based chocolate interventions are less standardized than quantified cocoa flavanol supplements

6) Grassi D, Desideri G, Necozione S, et al. Blood pressure is reduced and insulin sensitivity increased in glucose-intolerant, hypertensive subjects after 15 days of consuming high-polyphenol dark chocolate. J Nutr. 2008.

PMID: 18716168

DOI: https://doi.org/10.1093/jn/138.9.1671

Population: Adults with glucose intolerance and elevated blood pressure.

Design: Randomized clinical study comparing high-polyphenol dark chocolate with low-polyphenol white chocolate.

Key findings:
• Blood pressure reductions were reported following high-polyphenol dark chocolate intake
• Insulin sensitivity markers improved under study conditions
• Findings support vascular and metabolic biomarker research, though food-based chocolate products differ from standardized cocoa flavanol supplements

Exercise Performance and Physical Function

Evidence strength: Low to Moderate.

Cocoa flavanols have been studied for exercise-related vascular physiology, but evidence that these effects translate into meaningful performance improvements remains limited and inconsistent.

7) Taub PR, Ramirez-Sanchez I, Patel VD, et al. Beneficial effects of dark chocolate on exercise capacity in sedentary subjects: underlying mechanisms. A double blind, randomized, placebo controlled trial.Food Funct. 2016.

PMID: 27491778

DOI: https://doi.org/10.1039/c6fo00611f

Population: Sedentary middle-aged adults without regular exercise training.

Design: Randomized, double-blind, placebo-controlled clinical trial evaluating daily high-flavanol dark chocolate supplementation over three months.

Key findings:

• Dark chocolate supplementation improved exercise capacity under study conditions, including increases in peak oxygen consumption and exercise workload
• Improvements were accompanied by favorable changes in biomarkers related to nitric oxide bioavailability, mitochondrial function, and oxidative stress
• Findings suggest cocoa flavanols may support exercise-related vascular physiology, although additional studies are needed to determine whether similar benefits occur in trained athletes or translate into meaningful improvements in athletic performance

8) Patel RK, Brouner J, Spendiff O. Dark chocolate supplementation reduces the oxygen cost of moderate intensity cycling. J Int Soc Sports Nutr. 2015.

PMID: 26674253

DOI: https://doi.org/10.1186/s12970-015-0106-7

Population: Recreationally active adults.

Design: Randomized crossover study evaluating dark chocolate supplementation and cycling physiology.

Key findings:
• Dark chocolate supplementation reduced oxygen cost during moderate-intensity cycling under study conditions
• Effects were interpreted as potentially related to nitric oxide–mediated exercise physiology
• This was a small study using dark chocolate rather than a standardized cocoa flavanol extract, so direct applicability to cocoa flavanol supplements is limited‍

‍Cognitive Function

Evidence strength: Low to Moderate.

Human studies suggest cocoa flavanols may support selected measures of cognitive performance, especially in older adults or individuals with lower baseline vascular or cognitive function. Findings remain heterogeneous.

9) Desideri G, Kwik-Uribe C, Grassi D, et al. Benefits in cognitive function, blood pressure, and insulin resistance through cocoa flavanol consumption in elderly subjects with mild cognitive impairment: the Cocoa, Cognition, and Aging (CoCoA) study. Hypertension. 2012.

PMID: 22892813

DOI: https://doi.org/10.1161/HYPERTENSIONAHA.112.193060

Population: Older adults with mild cognitive impairment.

Design: Randomized controlled trial evaluating different cocoa flavanol intake levels.

Key findings:
• Improvements were reported in selected cognitive performance measures
• Blood pressure and insulin resistance markers also improved under study conditions
• Findings support further research into vascular-cognitive pathways, but should not be interpreted as evidence of disease treatment

10) Brickman AM, Khan UA, Provenzano FA, et al. Enhancing dentate gyrus function with dietary flavanols improves cognition in older adults. Nat Neurosci. 2014.

PMID: 25344629

DOI: https://doi.org/10.1038/nn.3850

Population: Healthy older adults.

Design: Randomized controlled trial evaluating high-flavanol intervention and cognitive/neuroimaging outcomes.

Key findings:
• Cocoa flavanol intake was associated with improvements in selected cognitive measures
• Neuroimaging findings suggested effects involving dentate gyrus function
• This trial provides mechanistically informative human data but involved a relatively small study population

11) Socci V, Tempesta D, Desideri G, et al. Enhancing human cognition with cocoa flavonoids. Front Nutr. 2017.

PMID: 28560212

DOI: https://doi.org/10.3389/fnut.2017.00019

Population: Human studies evaluating cocoa flavonoids and cognition.

Design: Review of human clinical research examining cognitive outcomes.

Key findings:
• Cognitive findings were most encouraging in older adults and selected cognitively demanding conditions
• Effects varied across dose, duration, and cognitive domain
• The review supports cautious interpretation of cocoa flavanols as an emerging area of cognitive-function research‍

Metabolic Health

Evidence strength: Low to Moderate.

Cocoa flavanols have been evaluated for insulin sensitivity, lipid biomarkers, and inflammatory markers. Findings are generally modest and less consistent than endothelial-function outcomes.

12) Shrime MG, Bauer SR, McDonald AC, et al. Flavonoid-rich cocoa consumption affects multiple cardiovascular risk factors in a meta-analysis of short-term studies. J Nutr. 2011.

PMID: 21918038

DOI: https://doi.org/10.3945/jn.111.145482

Population: Adults across short-term cocoa intervention studies.

Design: Meta-analysis evaluating cardiovascular and metabolic risk factors.

Key findings:
• Cocoa interventions were associated with changes in selected cardiometabolic biomarkers
• Effects were generally modest and varied across outcomes
• Findings support cocoa flavanols as a cardiometabolic research area, while highlighting the limitations of short-term biomarker-focused studies

13) Sesso HD, Manson JE, Aragaki AK, et al. Effect of cocoa flavanol supplementation for the prevention of cardiovascular disease events: the COcoa Supplement and Multivitamin Outcomes Study randomized clinical trial. Am J Clin Nutr. 2022.

PMID: 35294962

DOI: https://doi.org/10.1093/ajcn/nqac055

Population: Older adults participating in a large, randomized prevention trial.

Design: Large randomized, double-blind, placebo-controlled trial evaluating cocoa extract supplementation.

Key findings:
• Cocoa extract supplementation did not significantly reduce the primary composite cardiovascular outcome
• Secondary and adherence analyses suggested signals for cardiovascular mortality reduction
• The trial provides important long-term safety and outcome context, but findings should be interpreted cautiously because the primary endpoint was not statistically significant

‍ 

Educational Notice
These summaries are provided for educational purposes to review published scientific literature and should not be interpreted as medical advice, diagnosis, or treatment recommendations. Readers should consult qualified healthcare professionals for personal medical decisions.

‍FDA Disclaimer
These statements have not been evaluated by the U.S. Food and Drug Administration. Dietary supplements are not intended to diagnose, treat, cure, or prevent any disease.

‍FTC Affiliate Disclosure
‍Some pages on this website may contain affiliate links to products. If readers choose to purchase through those links, the site may receive a commission. Affiliate relationships do not influence the selection or discussion of scientific studies summarized on this reference page.